Incyte (INCY) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $126.75 -0.98%
Revenue Growth %: +7.3%
Financial Fact:
Diluted (in dollars per share): 0.19
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +7.3%
Financial Fact:
Diluted (in dollars per share): 0.19
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of $1.43, $0.08 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.14 billion.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
